Industry Background:
Due to upsurging health defects as well as growing instances of cardiac diseases has led to an increase in the demand for Transcatheter embolization devices across the globe. In addition to this, according to the National Cancer Institute at the National Institute of Health (NIH), around 1,658,370 new cancer cases will be diagnosed and around 589,430 people will die in 2015 in the U.S. alone. Taking into account the increasing prevalence of cancer, the global Transcatheter embolization devices market will show a significant demand over the forecasted period. The embolization coil is manufactured to hold PED in the distorted state until the parent vessel doesn’t deploy PED. These devices contain a permanent implant combined with a guidewire-based delivery system. The PED implant is multi-alloy, braided, mesh cylinder woven from cobalt-chromium-nickel alloy wires as well as platinum/tungsten. The embolization coils are produced by tungsten-platinum alloys. Moreover, the use of proximal pusher allows consumers to push PED out of the microcatheter when the wire is advanced.
Attributes | Details |
---|
Study Period | 2017-2027 |
Base Year | 2021 |
Unit | Value (USD Million) |
Key Companies Profiled | BTG PLC (United Kingdom), Boston Scientific Corporation (United States), Medtronic Plc (Ireland), Penumbra, Inc. (United States), Cook Medical (United States), Edwards Lifesciences Corporation (United States), Merit Medical Systems Inc. (United States), Johnson & Johnson Services Inc. (United States), Pfizer, Inc. (United States), Stryker Corporation (United States) and Terumo Corporation (Japan) |
According to AMA, the market for Transcatheter Embolization Device is expected to register a CAGR of 9.81% during the forecast period to 2027. This growth is primarily driven by Growing Instances of Chronic Diseases and Aging Population across the Globes and Mandatory Diagnosis and Regular Monitoring of Infected Patients will generate Significant Demand.
Globally, a noticeable market trend is evident Introduction to Transcatheter Closures with Comparatively Larger Ducts
. Major Players, such as BTG PLC (United Kingdom), Boston Scientific Corporation (United States), Medtronic Plc (Ireland), Penumbra, Inc. (United States), Cook Medical (United States), Edwards Lifesciences Corporation (United States), Merit Medical Systems Inc. (United States), Johnson & Johnson Services Inc. (United States), Pfizer, Inc. (United States), Stryker Corporation (United States) and Terumo Corporation (Japan) etc have either set up their manufacturing facilities or are planning to start new provision in the dominated region in the upcoming years.
On January 24th, 2019, Boston Scientific Corporation has launched the Vercise Primary Cell (PC) and Vercise Gevia Deep Brain Stimulation (DBS) Systems featuring the Vercise Cartesia Directional Lead. The new systems, which were recently approved by the U.S. Food and Drug Administration (FDA), feature technology designed to allow physicians to control the range, shape, position, and direction of electrical stimulation to treat the symptoms of Parkinson's disease (PD) through highly-personalized therapy.
Regulatory Insights:
According to the United States Food and Drug Administration (FDA), Transcatheter Embolization Device Labels must include instructions for use; Compatible transcatheter intracardiac procedure devices; a detailed summary of the clinical testing conducted; a shelf life and storage conditions and many others. Moreover, the device manufacturers must follow registration and list (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820).
Market Drivers
- Growing Instances of Chronic Diseases and Aging Population across the Globes
- Mandatory Diagnosis and Regular Monitoring of Infected Patients will generate Significant Demand
Market Trend
- Introduction to Transcatheter Closures with Comparatively Larger Ducts
- Consumer Paradigm Shift from Clipping to Coiling has improved the Demand
Restraints
- Comparatively Costlier Products than Other Healthcare Equipment
- Stringent Government Regulations and Approval Procedures
Opportunities
Growing Awareness and Attractiveness towards Non-Invasive or Minimally Invasive Surgeries and Upsurging Healthcare Infrastructure in Developing Countries like India and China
AMA Research follow a focused and realistic research framework that provides the ability to study the crucial market dynamics in several regions across the world. Moreover, an in-depth assessment is mostly conducted by our analysts on geographical regions to provide clients and businesses the opportunity to dominate in niche markets and expand in emerging markets across the globe. This market research study also showcase the spontaneously changing Players landscape impacting the growth of the market. Furthermore, our market researchers extensively analyse the products and services offered by multiple players competing to increase their market share and presence.
Customization in the Report
AMA Research features not only specific market forecasts, but also include significant value-added commentary on:
- Market Trends
- Technological Trends and Innovations
- Market Maturity Indicators
- Growth Drivers and Constraints
- New Entrants into the Market & Entry/Exit Barriers
- To Seize Powerful Market Opportunities
- Identify Key Business Segments, Market Proposition & Gap Analysis
Against this Challenging Backdrop, Transcatheter Embolization Device Study Sheds Light on
The Transcatheter Embolization Device Market status quo and key characteristics. To end this, Analyst at AMA organize and took survey of the Transcatheter Embolization Device industry Players. The resultant snapshot serves as a basis for understanding why and how the industry can be expected to change.
Where Transcatheter Embolization Device industry is heading and what are the top priorities. Insights are drawn from financial analysis, the survey and interviews with key executives and industry experts.
How every company in this diverse set of Players can best navigate the emerging competition landscape and follow a strategy that helps them position to hold value they currently claim, or capture the new addressable opportunity.